Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Psychoneuroendocrinology. 2022 Mar 25;141:105750. doi: 10.1016/j.psyneuen.2022.105750

Figure 3.

Figure 3.

Chronic nonapeptide administration. (a) Mean (±SE) latency (in seconds, s) to reach the platform across nine learning trials for animals receiving saline (diamonds), OT (squares), or AVP (triangles). (b) Mean (±SE) duration of time (in seconds) spent during the memory trial in the quadrant where a platform was previously located for animals chronically administered saline, OT, or AVP during adolescence. Bars show significant post hoc differences; * = p ≤ 0.05.